25C-NBOMe
Sign in to saveAlso known as 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
25C-NBOMe, also known as NBOMe-2C-C, 2C-C-NBOMe, or Cimbi-82, is a psychedelic drug and derivative of the psychedelic phenethylamine 2C-C. It acts as a potent agonist of the 5-HT2A receptor, and has been studied in its 11C radiolabelled form as a potential ligand for mapping the distribution of 5-HT2A receptors in the brain, using positron emission tomography (PET). Multiple deaths have occurred from usage of 25C-NBOMe due to the ease of accidental overdose. The long-term toxic effects of the drug have not been researched. 25C-NBOMe was first described in the scientific literature by 2010.
~6 min read
Encyclopedic overview
25 sectionsContents
- Use and effects
- Toxicity and harm potential
- Neurotoxic and cardiotoxic actions
- Emergency treatment
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Analogues
- History
- Society and culture
- Recreational use
- Legal status
- Canada
- China
- Czech Republic
- Israel
- New Zealand
- Russia
- Sweden
- United Kingdom
- United States
- Notes
- References
- External links
25C-NBOMe, also known as NBOMe-2C-C, 2C-C-NBOMe, or Cimbi-82, is a psychedelic drug and derivative of the psychedelic phenethylamine 2C-C. It acts as a potent agonist of the 5-HT2A receptor, and has been studied in its 11C radiolabelled form as a potential ligand for mapping the distribution of 5-HT2A receptors in the brain, using positron emission tomography (PET). Multiple deaths have occurred from usage of 25C-NBOMe due to the ease of accidental overdose. The long-term toxic effects of the drug have not been researched. 25C-NBOMe was first described in the scientific literature by 2010.
==Use and effects== left|thumb|Blotter paper containing 25C-NBOMe
Excerpted from Wikipedia’s “25C-NBOMe” article, available under the CC BY-SA 4.0 licence.